You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

Healthcare stocks slide

Capital Market 

Healthcare stocks were trading with losses, with the S&P BSE Healthcare index decreasing 231.33 points or 0.98% at 23450.54 at 13:48 IST.

Among the components of the S&P BSE Healthcare index, Suven Life Sciences Ltd (down 6.98%), Morepen Laboratories Ltd (down 4.95%),Vimta Labs Ltd (down 3.37%),Glenmark Pharmaceuticals Ltd (down 3.27%),Healthcare Global Enterprises Ltd (down 3.09%), were the top losers. Among the other losers were Gufic BioSciences Ltd (down 3.01%), Cipla Ltd (down 2.86%), Marksans Pharma Ltd (down 2.34%), Fortis Healthcare Ltd (down 2.28%), and Lincoln Pharmaceuticals Ltd (down 2.18%).

On the other hand, Alembic Ltd (up 8.54%), Caplin Point Laboratories Ltd (up 3.17%), and Laurus Labs Ltd (up 2.67%) turned up.

At 13:48 IST, the S&P BSE Sensex was down 86.09 or 0.18% at 48632.43.

The Nifty 50 index was down 29.3 points or 0.2% at 14604.85.

The S&P BSE Small-Cap index was up 44.83 points or 0.2% at 22055.97.

The S&P BSE 150 Midcap Index index was up 27.16 points or 0.39% at 7058.76.

On BSE,1536 shares were trading in green, 1323 were trading in red and 165 were unchanged.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, May 04 2021. 14:00 IST